Edition:
India

AC Immune SA (ACIU.OQ)

ACIU.OQ on NASDAQ Stock Exchange Global Market

5.03USD
24 May 2019
Change (% chg)

$0.18 (+3.71%)
Prev Close
$4.85
Open
$4.83
Day's High
$5.04
Day's Low
$4.83
Volume
24,277
Avg. Vol
92,809
52-wk High
$17.39
52-wk Low
$3.25

Select another date:

Wed, Jan 30 2019

UPDATE 1-Roche drops Alzheimer drug trials after setback

* Roche was working on crenezumab with AC Immune (Adds Roche, AC Immune comments)

Lilly partners with AC Immune for Alzheimer's treatment

Eli Lilly & Co and AC Immune SA have agreed to jointly develop a potential treatment for Alzheimer's disease.

Lilly partners with AC Immune for Alzheimer's treatment

U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

UPDATE 1-Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 U.S. drugmaker Eli Lilly & Co and AC Immune SA have agreed to jointly develop the Swiss biotech's potential treatment for Alzheimer's disease.

Lilly partners with AC Immune for Alzheimer's treatment

Dec 12 Eli Lilly & Co and AC Immune SA have agreed to jointly develop a potential treatment for Alzheimer's disease.

Select another date: